Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.

The Company has previously filed its Form 10-Q for the quarterly periods ended March 31, 2023, June 30, 2023 and September 30, 2023 ("Previously Issued Financial Statements").

On April 16, 2024, the Company's management concluded that the Company's Previously Issued Financial Statements should be restated and no longer relied upon due to the Company not appropriately accounted for its research and development intellectual property rights, including the recording of the expense and its corresponding accounts payable. Additionally, the total number of common shares outstanding as of December 31, 2022 were incorrectly reflected as 202,704,211 shares when the actual number of outstanding shares was 7,642,211, resulting in a reclassification of $19,506 from common stock at par to additional paid in capital on the December 31, 2022 Condensed Consolidated Balance Sheet and the Condensed Consolidated Statements of Stockholders' Deficit for the three months ended March 31, 2023 and 2022, the three and six months ended June 30, 2023 and 2022, and the three and nine months ended September 30, 2023 and 2022.

As such, in 2022, the Company, through its Australian subsidiary, entered into a binding term sheet to transfer $1,000,000 AUD in the Company's shares to a third-party in exchange for certain intellectual property. During the first quarter of 2023, the Company took possession of the intellectual property and commenced a trial period to review the intellectual property; however, the Company determined that the intellectual property was not viable for their operations and returned the intellectual property to the third-party. Since the Company took possession of the intellectual property, it recognized the related expense during the first quarter March 31, 2023; however, in April 2024, the Company and the third-party entered into a binding recission whereby certain intellectual property rights were rescinded and the third-party waived and discharged its rights and interest to the $1,000,000 AUD of shares of the Company.

Management has thoroughly discussed with the Company's independent accountant the matters disclosed in the filing pursuant to this Item 4.02(a).

2

Attachments

  • Original Link
  • Permalink

Disclaimer

Prevention Insurance.com published this content on 20 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2024 20:01:02 UTC.